← All organizations
Sinovac Biotech Co., Ltd
For profitWebsite ↗
Also known as: Sinovac Biotech (Chile) SpA | Sinovac Biotech (Colombia) S.A.S. | Sinovac Biotech Co., Ltd | Sinovac Biotech (Hong Kong) Limited | Sinovac (Dalian) Vaccine Technology Co., Ltd. | Sinovac Research and Development Co., Ltd.
Highest phase reached
Phase 4
First clinical trial
Dec 1, 2005Last known activity
Mar 1, 2026
Defunct as of Apr 1, 2018
Timeline
1990s
- Jul 1, 1999
Sinovac Biotech Co., Ltd— Founded
2010s
- Apr 1, 2018
Sinovac Biotech Co., Ltd— Defunct
Drugs by trial phase (32 distinct, 107 trials)
Phase 4 (23 own, 0 via acquisition)
- 23-valent pneumococcal polysaccharide vaccine
- methylprednisolone
- aluminum hydroxide
- hepatitis b vaccine (recombinant)
- hepatitis a vaccine, inactivated
- ev71 vaccine
- inactivated influenza vaccine
- attenuated live hepatitis A vaccine
- live attenuated varicella vaccine
- measles, mumps, and rubella vaccine
- inactivated varicella vaccine
- vasopressin
- acellular pertussis vaccine (including diptheria and tetanus toxoids)
- Mumps virus vaccine live
- hepatitis-a virus (inactivated) / hepatitis-b surface antigen
- +8 more
Phase 3 (8 own, 0 via acquisition)
- inactivated rabies vaccine
- live oral poliovirus type 1, 2 and 3
- live attenuated mumps vaccine (Jeryl Lynn strain)
- bivalent oral polio vaccine (bopv), type 1 and type 3
- polio, inactivated poliovirus vaccine
- coronavac
- omicron covid-19 vaccine (vero cell), inactivated
- trivalent covid-19 vaccine (vero cell), inactivated, prototype strain, delta strain and omicron strain
Phase 1 (1 own, 0 via acquisition)
Indications
Recent trials (50)
- NCT07055295Lead sponsorPhase 3Mar 1, 2026
- NCT07055893Lead sponsorPhase 3Mar 1, 2026
- NCT07211152Lead sponsorPhase 3Nov 30, 2025
- NCT07055880Lead sponsorPhase 2Jul 28, 2025
- NCT06891872Lead sponsorPhase 4May 31, 2025
- NCT06754384Lead sponsorPhase 1/Phase 2Jan 30, 2025
- NCT06734832Lead sponsorPhase 3Dec 30, 2024
- NCT06484686Lead sponsorPhase 4Sep 30, 2024
- NCT06994052Lead sponsorPhase 4Sep 21, 2024
- NCT06987942Lead sponsorPhase 4Sep 21, 2024
- NCT06442449Lead sponsorPhase 4Jul 10, 2024
- NCT06346834Lead sponsorPhase 4Apr 30, 2024
- NCT06314724Lead sponsorPhase 3Mar 1, 2024
- NCT06183216Lead sponsorPhase 1Jan 4, 2024
- NCT06576024CollaboratorPhase 4Dec 19, 2023
Details
- Founded
- Beijing, CN Jul 1, 1999
- Last known activity
- Mar 1, 2026
Notes
--- Pre-folding founded info: 2001-06-01 Beijing None China https://www.bloomberg.com/research/stocks/private/snapshot.asp?privcapId=13191009 ---